Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Men with urinary issues often don't stick to their medication long-term.

Apremilast showed mixed results for treating severe alopecia areata.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

A man had bad reactions to a hair loss treatment called DNCB.

Most men stopped using the hair loss treatment not because of sexual side effects, but because they didn't see positive results.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Sulfasalazine may help treat persistent alopecia areata.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Promising cancer treatments were found, but the manufacturer closed.

Minoxidil effectively lowers blood pressure in patients with resistant hypertension.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Minoxidil therapy can help with hair regrowth, but results vary and some people are just happy to stop further hair loss.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

The study's findings on omega-6 and hair loss are unreliable.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.